-

Claritev Invests in Klaim, Inc. to Accelerate Provider Payment Solutions Across the U.S. and MENA Region

The investment expands Claritev’s presence in the MENA region connecting Claritev’s U.S. presence with Klaim’s healthcare-fintech expertise from the Middle East.

MCCLEAN, Va. & RIYADH, Saudi Arabia--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a global leader in healthcare analytics and claims analysis, today announced a strategic investment in Klaim, Inc., an AI-driven healthcare payment-acceleration solutions provider. The investment will help fund the launch of a co-branded Payment Acceleration Service integrated within Claritev’s extensive provider network, helping healthcare organizations gain faster and more predictable access to reimbursements across the U.S. and MENA regions.

This investment and relationship strengthen Claritev’s strategic expansion in the MENA region while supporting Klaim’s expansion across the U.S. Together, the companies can combine Claritev’s deep payor-provider infrastructure and ACE analytics platform with Klaim’s proven payment-acceleration technology, aiming to set a new benchmark for liquidity access and operational efficiency in healthcare finance.

The Claritev–Klaim Payment Acceleration platform is designed to allow eligible healthcare providers in the U.S. and MENA region to convert pending insurance claims into near-instant liquidity, reducing the typical 30–120-day reimbursement cycle.

As part of the collaboration, Klaim will leverage Claritev’s Advanced Code Editing (ACE) technology for claim coding intelligence to enable evaluation of claims qualified for funding.

Additional key benefits to participating providers are anticipated to include:

  • Certainty of payment for qualifying claims and reduced risk of cash flow gaps due to denials or delays
  • Flexible usage as providers can choose the volume of claims to accelerate, based on their working capital needs
  • Reduced administrative burden as Klaim undertakes reconciliation and payor follow-up for accelerated claims
  • Scalable access, making the platform suitable for small clinics, large hospitals and multi-specialty networks

“Our investment in Klaim reflects Claritev’s commitment to modernizing provider cash flow and strengthening financial resilience across the healthcare system,” said Will Mintz, Chief Strategy Officer at Claritev. “By combining Claritev’s trusted provider relationships and ACE technology with Klaim’s fintech infrastructure, we’re helping providers get paid faster and operate with greater confidence.”

“This relationship is about unlocking liquidity at scale for healthcare providers,” added Karim Dakki, Co-Founder & CEO of Klaim. “Together with Claritev, we’re bringing a data-driven solution that turns delayed reimbursements into predictable cash flow, helping practices stay focused on delivering care rather than chasing payments. The investment also marks the beginning of Klaim’s global restructuring, which is anticipated to bring together Klaim Middle East (under Klaim Holdings Limited) and Klaim, Inc. under a planned global holding company.”

About Claritev

Claritev is a healthcare technology, data and insights company focused on improving affordability, transparency and quality. Led by a team of deeply experienced associates, data scientists and innovators, Claritev provides tech-enabled solutions and services fueled by multiple data sources and over 40 years of claims repricing experience. Claritev utilizes world-class technology and AI solutions to power a robust enterprise platform that delivers meaningful insights to drive affordability in healthcare, brings price transparency and optimizes networks and benefits design. By focusing on purpose-built solutions that support all key players—including payors, employers, patients, providers and third parties—Claritev aims to make healthcare more accessible and affordable for all.

Claritev serves more than 700 healthcare payors, over 100,000 employers, 60 million consumers, and 1.4 million contracted providers. For more information, visit claritev.com.

About Klaim, Inc.

Klaim, Inc. is healthcare-fintech company founded by Karim Dakki and Ghafoor Ahmad. Klaim enables healthcare providers to accelerate insurance reimbursements and improve cash flow predictability through proprietary AI-powered funding technology. By converting pending claims into cash within 24 hours, Klaim helps providers reduce administrative delays and strengthen financial resilience. Visit Klaim.com for more information.

Contacts

Media Relations

Pamela Walker
VP, Marketing
Claritev
781-895-3118
press@claritev.com

Investor Relations

Todd Friedman
VP, Investor Relations
Claritev
866-909-7427
investor@claritev.com

Claritev Corporation

NYSEAM:CTEV
Details
Headquarters: McLean, VA
CEO: Travis Dalton
Employees: 2800
Organization: PUB

Release Versions

Contacts

Media Relations

Pamela Walker
VP, Marketing
Claritev
781-895-3118
press@claritev.com

Investor Relations

Todd Friedman
VP, Investor Relations
Claritev
866-909-7427
investor@claritev.com

More News From Claritev Corporation

Claritev Selected by GDIT to Support CDC’s World Trade Center Health Program

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (NYSE: CTEV), a healthcare technology, data, and insights company focused on making healthcare more affordable, transparent and fair for all, has been selected by General Dynamics Information Technology (GDIT) to support the World Trade Center (WTC) Health Program. The WTC Health Program is a limited federal health care program established under the James Zadroga 9/11 Health and Compensation Act of 2010 (Extended in 2015). It provides nationwid...

Claritev Releases 2025 Corporate Responsibility Report

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation ("Claritev" or the "Company") (NYSE: CTEV), a healthcare technology, data, and insights company, today announced the publication of its 2025 Corporate Responsibility Report. The report highlights progress across Claritev’s corporate responsibility priorities, including responsible AI, employee engagement, community impact, and sustainable operations. Throughout 2025, the Company remained focused on advancing transparency and affordability acros...

Claritev Appoints Ben Letham to its Board of Directors

MCLEAN, Va.--(BUSINESS WIRE)--Claritev Corporation (“Claritev” or the “Company”) (NYSE: CTEV), a technology, data, and insights company, today announced that its Board of Directors (“Board”) has appointed Ben Letham as a director, effective September 14, 2026, to fill a vacancy on the Board. Letham’s extensive experience in artificial intelligence (AI) will enhance the Board’s depth of expertise and support the Company’s long-term strategic objectives. Letham is a leader in AI and optimization...
Back to Newsroom